Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Chipman Robert Geoffrey Stroud"'
Autor:
Sweta Jonnalagadda, Alessio Cortellini, Nitika Sharma, Daria Gramenitskaya, Kevin O'Brien, Emma Mi, Mahvish Muzaffar, Shravanti Macherla, David J. Pinato, Shanker Polsani, Abdul Rafeh Naqash, Chipman Robert Geoffrey Stroud, Jussi Koivunen, James Clark, Rahim Jiwani, Paul R. Walker, Sanna Livanainen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background CRP is an acute-phase protein produced primarily in response to interleukin IL-6 via transcriptional activation of the STAT3. Recent data have provided mechanistic insights into the immune suppressive role of elevated CRP by elucidating it
Autor:
Maida Hafiz, Li V. Yang, Mahvish Muzaffar, Aparna Madhukeshwar Hegde, Grace K. Dy, Chipman Robert Geoffrey Stroud, Muhammad Butt, Cynthia R. Cherry, Abdul Rafeh Naqash, Paul R. Walker
Publikováno v:
Acta Oncologica. 57:867-872
Co-relation of overall survival with peripheral blood-based inflammatory biomarkers in advanced stage non-small cell lung cancer treated with anti-programmed cell death-1 therapy: results from a single institutional database
Publikováno v:
Journal of Clinical Oncology. 37:e14200-e14200
e14200 Background: Lung Cancer remains the major cause of cancer related mortality in the state of North Carolina. There is a growing body of evidence that implicates inflammation as a mechanism of disease progression and reduced survival in patients
Autor:
Jessica Hardin, Cynthia R. Cherry, Chipman Robert Geoffrey Stroud, Teresa Parent, Paul R. Walker, Aparna Madhukeshwar Hegde, Abdul Rafeh Naqash
Publikováno v:
Journal of Thoracic Oncology. 12:S1554-S1555
Autor:
Mark R. Bowling, Chipman Robert Geoffrey Stroud, Maida Hafiz, Abdul Rafeh Naqash, Paul R. Walker
Publikováno v:
Journal of Thoracic Oncology. 12:S1568-S1569
Autor:
Mahvish Muzaffar, Abdul Rafeh Naqash, Li V. Yang, Paul R. Walker, Chipman Robert Geoffrey Stroud
Publikováno v:
Cancer Research. 78:1691-1691
Background: Immune-checkpoint blockade (ICB) using antibodies directed against the programmed cell death-1 (PD-1) axis has revolutionized the management of non-small cell lung cancer (NSCLC). Based on results from the Checkmate 017 and 057, nivolumab
Autor:
Cynthia R. Cherry, Mohammed Umer Butt, Li V. Yang, Nitika Sharma, Chipman Robert Geoffrey Stroud, Mahvish Muzaffar, Abdul Rafeh Naqash, Paul R. Walker
Publikováno v:
Journal of Clinical Oncology. 36:e15122-e15122
e15122Background: Quantification of baseline systemic inflammation using readily available peripheral blood-derived inflammatory biomarkers such as CRP has demonstrated prognostic and predictive ut...
Autor:
Cynthia R. Cherry, Paul R. Walker, Nitika Sharma, Mark R. Bowling, Aparna Madhukeshwar Hegde, Tien Phuc Do, Chipman Robert Geoffrey Stroud, Sulochana Devi Cherukuri
Publikováno v:
Journal of Clinical Oncology. 36:e15109-e15109
e15109Background: Recent evidence indicates that the gut microbiome modulates immunotherapy responses in multiple tumor types. Some studies report antibiotics (ATB) may alter the microbiota composi...
Autor:
A.W. Ju, Cynthia R. Cherry, Sulochana Devi Cherukuri, Nitika Sharma, Paul R. Walker, Aparna Madhukeshwar Hegde, Chipman Robert Geoffrey Stroud, Mark R. Bowling, Hyder Husain Arastu
Publikováno v:
Journal of Clinical Oncology. 36:e21070-e21070
e21070Background: In lung cancer patients receiving immunotherapy, radiographic disease progression (PD) has poor correlation with overall survival (OS) due to unconventional response patterns. The...
Autor:
Chipman Robert Geoffrey Stroud, Paul R. Walker, Nitika Sharma, Sulochana Devi Cherukuri, Mark R. Bowling, Cynthia R. Cherry, Aparna Madhukeshwar Hegde, Ramya Pinnamaneni, A.W. Ju, Hyder Husain Arastu
Publikováno v:
Journal of Clinical Oncology. 36:e21134-e21134
e21134Background: In advanced non- small cell lung cancer, when compared with Docetaxel, the absolute improvement in one- year overall survival (OS) with nivolumab monotherapy (Checkmate 017 and 05...